Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Hold from Kepler Capital

Tipranks - Tipranks - Fri Jan 23, 8:16PM CST

Kepler Capital analyst Oliver Reinberg maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA on January 21 and set a price target of €49.00. The company’s shares closed last Wednesday at €36.63.

Claim 50% Off TipRanks Premium

According to TipRanks, Reinberg is an analyst with an average return of -5.0% and a 42.62% success rate. Reinberg covers the Healthcare sector, focusing on stocks such as Fresenius Medical Care AG & Co. KGaA, STRATEC Biomedical, and Carl Zeiss Meditec.

Currently, the analyst consensus on Fresenius Medical Care AG & Co. KGaA is a Hold with an average price target of €43.74, representing a 19.41% upside. In a report released on January 20, Goldman Sachs also downgraded the stock to a Hold with a €40.00 price target.

See the top stocks recommended by analysts >>

The company has a one-year high of €54.02 and a one-year low of €35.67. Currently, Fresenius Medical Care AG & Co. KGaA has an average volume of 814.7K.

Read More on GB:0H9X:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).